Ads
related to: LVTX Stock
Search results
Can LAVA Therapeutics N.V. (LVTX) Climb 198% to Reach the Level Wall Street Analysts Expect?
Zacks via Yahoo Finance· 2 years agoThe mean of analysts' price targets for LAVA Therapeutics N.V. (LVTX) points to a 197.6% upside in...
LAVA Therapeutics N.V. (LVTX) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
Zacks via Yahoo Finance· 2 years agoLAVA Therapeutics N.V. (LVTX) possesses the right combination of the two key ingredients for a...
LAVA (LVTX) Up on J&J's (JNJ) Cancer Study Candidate Selection
Zacks via Yahoo Finance· 12 months agoLAVA Therapeutics’ LVTX shares were up almost 27% on Jun 1, after market hours. This followed soon...
LAVA Therapeutics N.V.'s (NASDAQ:LVTX) market cap surged US$60m last week, private equity firms who...
Simply Wall St. via Yahoo Finance· 2 years agoTo get a sense of who is truly in control of LAVA Therapeutics N.V. (NASDAQ:LVTX), it is important...
LAVA Therapeutics N.V. (LVTX) Q3 Earnings Surpass Estimates
Zacks via Yahoo Finance· 2 years agoLAVA Therapeutics N.V. (LVTX) delivered earnings and revenue surprises of 157.14% and 38.96%,...
Investors in LAVA Therapeutics (NASDAQ:LVTX) have unfortunately lost 31% over the last year
Simply Wall St. via Yahoo Finance· 2 years agoIt is a pleasure to report that the LAVA Therapeutics N.V. (NASDAQ:LVTX) is up 97% in the last...
LAVA Therapeutics N.V.'s (NASDAQ:LVTX) Business And Shares Still Trailing The Industry
Simply Wall St. via Yahoo Finance· 1 year agoLAVA Therapeutics N.V.'s (NASDAQ:LVTX) price-to-sales (or "P/S") ratio of 2.3x might make it look...
Analyst Says This Small Cap Stock Might Be 'Game Changer' In Bispecific T Cell Engagers Space
Benzinga via Yahoo Finance· 2 years agoHC Wainwright initiated coverage on LAVA Therapeutics NV (NASDAQ: LVTX) with a Buy rating and a...
Why Is Cancer Focused LAVA Therapeutics Nano Cap Stock Trading Higher Today?
Benzinga via Yahoo Finance· 4 months agoLAVA Therapeutics NV (NASDAQ:LVTX) has entered into a clinical trial collaboration and supply...
LAVA Therapeutics Highlights Encouraging Clinical Updates on Lead Cancer Program
Benzinga via Yahoo Finance· 2 years agoLAVA Therapeutics N.V. (NASDAQ: LVTX) hosted a clinical update call focused on initial Phase 1/2a...
